日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers

2025年泌尿系统晚期肿瘤共识会议(AUC3):肾细胞癌和泌尿系统肿瘤治疗的专家共识

McKay, Rana R; Pal, Sumanta; Xie, Wanling; Aggen, David; Albiges, Laurence; Apolo, Andrea; Atkins, Michael B; Bangs, Rick; Beckermann, Kathryn E; Bellmunt, Joaquim; Berg, Stephanie A; Bilen, Mehmet A; Braun, David; Carlo, Maria I; Efstathiou, Jason; Galsky, Matthew; Grivas, Petros; Gupta, Shilpa; Haas, Naomi; Hakimi, A Ari; Hammers, Hans; Heng, Daniel Y C; Hirsch, Michelle; Iyer, Gopakumar; Jonasch, Eric; Koshkin, Vadim S; Kryvenko, Oleksandr; Lewis, Bryan; Li, Roger; Matin, Surena; Maughan, Benjamin; McDermott, David F; McGregor, Bradley; Meeks, Joshua; Milowsky, Matthew; Motzer, Robert; Necchi, Andrea; Petrylak, Dan; Porten, Sima; Powles, Thomas; Rini, Brian; Shuch, Brian; Siefker-Radtke, Arlene; Sonpavde, Guru; Sridhar, S Srikala; Suarez, Cristina; Tang, Chad; Tripathi, Abhishek; Van Der Heijden, Michiel S; Voss, Martin; Xu, Wenxin; Zhang, Tian; Rosenberg, Jonathan; Choueiri, Toni K

Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial

CheckMate 9ER 随机 III 期试验中,对纳武利尤单抗联合卡博替尼治疗晚期肾细胞癌的最终分析

Motzer, R J; Escudier, B; Burotto, M; Powles, T; Apolo, A B; Bourlon, M T; Shah, A Y; Porta, C; Suárez, C; Barrios, C H; Richardet, M; Gurney, H; Kessler, E R; Tomita, Y; Bedke, J; Scheffold, C; Askelson, M; Panzica, J; Zhang, J; van Kooten Losio, M; Choueiri, T K

Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma

可溶性MAdCAM-1作为转移性肾细胞癌的生物标志物

Alves Costa Silva, Carolina; Machaalani, Marc; Saliby, Renee Maria; Zhong, Caiwei; Xie, Wanling; Pasolli, Edoardo; Piccinno, Gianmarco; Dalban, Cécile; Fidelle, Marine; Meurisse, Aurelia; Vernerey, Dewi; Lee, Gwo-Shu Mary; Birebent, Roxanne; Saad, Eddy; Steiner, Clara; Flippot, Ronan; Barros-Monteiro, Janice; Segata, Nicola; Thiery-Vuillemin, Antoine; Formenti, Silvia; Kuznetsova, Tatiana; Escudier, Bernard; Derosa, Lisa; Zitvogel, Laurence; Choueiri, Toni K; Albiges, Laurence

Publisher Correction: argeting of HIF2-driven cachexia in kidney cancer

出版商更正:针对肾癌中 HIF2 驱动的恶病质的治疗

Abu-Remaileh, Muhannad; Stransky, Laura A; Bhalerao, Nikita; Shirole, Nitin H; Jiang, Qinqin; Saad, Eddy; Machaalani, Marc; Vigeant, Sean M; Woldemichael, Hilina; Xu, Charles; Lu, Jing; Wei, Hairong; Liu, Zhihong; Sun, William; Enomoto, Kei; Choueiri, Toni K; Pitarresi, Jason R; Carr, Steven A; Udeshi, Namrata D; Kaelin, William G Jr

Targeting of HIF2-driven cachexia in kidney cancer.

针对肾癌中由HIF2驱动的恶病质的靶向治疗。

Abu-Remaileh Muhannad, Stransky Laura A, Bhalerao Nikita, Shirole Nitin H, Jiang Qinqin, Saad Eddy, Machaalani Marc, Vigeant Sean M, Woldemichael Hilina, Xu Charles, Lu Jing, Wei Hairong, Liu Zhihong, Sun William, Enomoto Kei, Choueiri Toni K, Pitarresi Jason R, Carr Steven A, Udeshi Namrata D, Kaelin William G Jr

Precision Oncology 2.0: Guiding Magic Bullets With Expression-Based Liquid Biopsy

精准肿瘤学 2.0:利用基于表达谱的液体活检指导精准治疗

Gulati, Gunsagar S; Choueiri, Toni K; Freedman, Matthew L; Baca, Sylvan C

Cell-free DNA epigenomic profiling enables noninvasive detection and monitoring of translocation renal cell carcinoma.

无细胞DNA表观基因组分析能够对易位性肾细胞癌进行无创检测和监测。

Garinet Simon, Semaan Karl, Li Jiao, Zhang Ze, Konda Prathyusha, Sadagopan Ananthan, Canniff John, Phillips Noa, Klega Kelly, Pandey Medha, Savignano Hunter, Davidsohn Matthew P, Lyons Kevin, Medda Alessandro, Khanna Prateek, Achom Mingkee, Fortunato Brad J, Nawfal Rashad, El Hajj Chehade Razane, O'Toole Jillian, Horst Jack, Freeman Dory, Trowbridge Rachel, Chau Cindy H, Figg William D, Berchuck Jacob E, Crompton Brian D, Seo Ji-Heui, Choueiri Toni K, Freedman Matthew L, Baca Sylvan C, Viswanathan Srinivas R

Single-cell epigenetic profiling reveals a tumor-intrinsic interferon response program in ccRCC tied to poor prognosis and BAP1 loss

单细胞表观遗传学分析揭示了透明细胞肾细胞癌中一种与预后不良和BAP1缺失相关的肿瘤内在干扰素反应程序。

Camp, Sabrina Y; He, Meng Xiao; Cuoco, Michael S; Garza, Amanda E; Xirenayi, Sherin; Bakouny, Ziad; Saad, Eddy; El Masri, Jad; Pimenta, Erica; Meli, Kevin; Labaki, Chris; Titchen, Breanna M; Kang, Yun Jee; Horst, Jack; Trowbridge, Rachel; Shannon, Erin; Helvie, Karla; Thorner, Aaron R; Vigneau, Sébastien; Mayorga, Angie; Kodali, Jahnavi; Lachmayr, Hannah; Bemus, Meredith; Chen, Pengsheng; Deng, Haiteng; Park, Jihye; Choueiri, Toni K; Bi, Kevin; Van Allen, Eliezer M

Partitioned overall survival: comprehensive analysis of survival states over 4 years in CheckMate 9ER comparing first-line nivolumab plus cabozantinib versus sunitinib in advanced renal cell carcinoma

分区总生存期:CheckMate 9ER 研究中对晚期肾细胞癌一线治疗方案(纳武利尤单抗联合卡博替尼与舒尼替尼)4 年生存状态的综合分析

Viray, Hollis; M Mantia, Charlene; Jegede, Opeyemi A; Atkins, Michael B; Rosenblatt, Lisa; Choueiri, Toni K; McDermott, David F; Regan, Meredith M

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0

癌症免疫治疗学会 (SITC) 肾细胞癌免疫治疗临床实践指南,第 3.0 版

McKay, Rana R; Ajmera, Archana; Atkins, Michael B; Barata, Pedro C; Bergerot, Cristiane; Bukavina, Laura; Choueiri, Toni K; Desai, Arpita; Hakimi, A Ari; Poteat, Susan; Powles, Thomas; Rini, Brian I; Shuch, Brian; Signoretti, Sabina; Siva, Shankar; Xu, Wenxin; Yip, Wesley; Zhang, Tian; Pal, Sumanta K